To investigate expenditure on PD research as a platform for advocacy is to sink immediately into a sea of complications. The US is possibly the most transparent jurisdiction in the world on medical spending, so let’s start with US spending on PD research. In 2017 it was $177m, with a reduction to $169m in prospect […]
Kevin McFarthing: “I was diagnosed with Parkinson’s in 2012. As a scientist, I tried to find out as much as I could about the condition. Part of that was to investigate potential therapies that may be of benefit in the future. This resulted in an ad ho list that needed organising in a spreadsheet. Following lots of […]
Below is a clip from a couple of years ago with me getting freezing-of-gait, a mysterious symptom of PD. Below is a blog post that was first published on my website, www.riggare.se, in March 2016. Looking back at that post now, two years later, I actually find myself having to look for new ways forward. […]
The following first appeared on tmrwedition. Prof. Patrik Brundin leads the Center for Neurodegenerative Science at Van Andel Research Institute where his research team is focused on experimental models and novel therapies in Parkinson’s disease. Dr. Brundin is one of the most cited scientists in neurodegenerative diseases, with a focus on Parkinson’s, and has received numerous […]
Here are some of the most important unanswered questions in Parkinson’s disease research from some of the leading figures in the field. This post first appeared on the Tomorrow Edition website.